Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

COX-2 inhibitors from Chugai

Oct. 17, 1997

New antiarthritic agents described by Procter & Gamble

Oct. 15, 1997

Verigen licenses Italian rights to anti-TNF-alpha product

Oct. 14, 1997

Eltenac efficacy demonstrated in osteoarthritis

Oct. 13, 1997

FDA grant awarded for research on Dupuytren's disease therapy

Oct. 8, 1997

Clinical pharmacokinetic profile of rhIL-10

Oct. 8, 1997

Celgene initiates clinical trials for novel TNF-alpha inhibitors

Oct. 6, 1997

BB-2983 development discontinued

Oct. 6, 1997

Wyeth-Ayerst to promote Immunex's ENBREL in U.S.

Oct. 3, 1997

Genelabs Technologies reports phase III results from SLE trial

Oct. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...